venlafaxine 37.5 mg

1 INDICATIONS AND USAGE Venlafaxine hydrochloride extended-release capsules are indicated in adults for the treatment of: major depressive disorder (MDD) [see Clinical Studies (14.1) ] Generalized Anxiety Disorder (GAD) [see Clinical Studies (14.2) ] Social Anxiety Disorder (SAD) [see Clinical Studies (14.3) ] Panic Disorder (PD) [see Clinical Studies (14.4) ] Venlafaxine hydrochloride extended-release capsules are a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of adults with: major depressive disorder (MDD) (1) Generalized Anxiety Disorder (GAD) (1) Social Anxiety Disorder (SAD) (1) Panic Disorder (PD) (1)

american health packaging

FDA Reported Adverse Reactions
`[1] nausea` `[2] drug ineffective` `[3] fatigue` `[4] pain` `[5] diarrhoea` `[6] vomiting` `[7] dyspnoea` `[8] headache` `[9] off label use` `[10] arthralgia`

5 years ago

CAPSULE GREY E 73

16 HOW SUPPLIED/STORAGE AND HANDLING

More pills like CAPSULE E 73

Related Pills

venlafaxine 75 mg

American Health Packaging

venlafaxine 150 mg

American Health Packaging

DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site